Susquehanna Fundamental Investments’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-38,294
Closed -$625K – 925
2025
Q1
$625K Buy
38,294
+1,288
+3% +$22.6K 0.01% 794
2024
Q4
$646K Buy
+37,006
New +$643K 0.01% 812
2021
Q3
– Sell
-5,902
Closed -$237K – 1833
2021
Q2
$237K Sell
5,902
-1,976
-25% -$83.5K ﹤0.01% 1434
2021
Q1
$342K Buy
7,878
+460
+6% +$20.3K 0.01% 1265
2020
Q4
$319K Sell
7,418
-5,262
-41% -$192K 0.01% 1255
2020
Q3
$395K Buy
12,680
+1,900
+18% +$58.9K 0.01% 967
2020
Q2
$345K Buy
+10,780
New +$358K 0.02% 708

Other funds holding OFIX

Susquehanna Fundamental Investments's OFIX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Orthofix Medical (OFIX) in Q2 2025, closing a stake of 38,294 shares — an estimated $625K sold.

Susquehanna Fundamental Investments first reported a position in OFIX in Q2 2020 and held it in 7 quarters. The position peaked at $646K in Q4 2024. 158 funds tracked by Wall St. Rank hold OFIX as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Orthofix Medical position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 38,294 Orthofix Medical shares in Q2 2025, an estimated $625K.
  • Susquehanna Fundamental Investments first reported a position in Orthofix Medical in Q2 2020 and held it in 7 quarters.
  • Susquehanna Fundamental Investments's Orthofix Medical position peaked at $646K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.